We are Developing and Moving Forward•••
-
January 2022
Signed contracts for and carried out CDMO projects, with many projects under discussion
-
December 2021
Completed utility systems, production qualification and engineering runs for protein production in Taicang facilities; The team members in BioInno exceeded 100 employees
-
November 2021
Completed round A financing; Hangzhou Tailong Capital and China Industrial International Trust Limited jointly led the investment; production capacity of Taicang facilities greatly increased
-
May 2021
Equipment for Taicang facilities arrived at the site
-
February 2021
Completed the Pre-A round of financing; Tigermed and TigerYear Capital led investment
-
October 2020
Installation of Taicang facilities started; Suzhou R&D laboratory construction started
-
July 2020
Angel round financing led to the strategic investment of TigerYear Capital (Tigermed Fund)
-
February 2020
With the support from local government, BioInno settled in Taicang Biomedical Industrial Park, started design for BioInno facilities with 12,000 square meters, and reserved 7 hectares industrial land for future development.
-
November 2019
BioInno Bioscience was founded